Clinical Trial Update: Cognitive Function After Treatment of Primary CNS Malignancy

View source ↗

Summary

A completed Mayo Clinic clinical trial evaluating cognitive function after treatment for primary central nervous system tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Neoplasms

Snippet

Sponsor: Mayo Clinic | Conditions: CNS Malignancy | Status: COMPLETED